• 1
    Sugasawa Y, Yamaguchi K, Kumakura S, et al. The effect of one-lung ventilation upon pulmonary inflammatory responses during lung resection. Journal of Anesthesia 2011; 25: 1707.
  • 2
    Zingg U, Forberger J, Frey DM, et al. Inflammatory response in ventilated left and collapsed right lungs, serum and pleural fluid, in transthoracic esophagectomy for cancer. European Cytokine Network 2010; 21: 507.
  • 3
    Tachibana M, Abe S, Tabara H, et al. One-lung or two-lung ventilation during transthoracic oesophagectomy? Canadian Journal of Anesthesia 1994; 41: 7105.
  • 4
    Lases EC, Duurkens VA, Gerritsen WB, Haas FJ. Oxidative stress after lung resection therapy: a pilot study. Chest 2000; 117: 9991003.
  • 5
    Misthos P, Katsaragakis S, Milingos N, et al. Postresectional pulmonary oxidative stress in lung cancer patients: the role of one-lung ventilation. European Journal of Cardiothoracic Surgery 2005; 27: 37982.
  • 6
    Tremblay LN, Slutsky AS. Pathogenesis of ventilator induced lung injury: trials and tribulations. American Journal of Physiology Lung Cellular Molecular Physiology 2005; 288: L5968.
  • 7
    Sato N, Koedo K, Kimura Y, et al. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. European Surgical Research 2001; 33: 27984.
  • 8
    Tekinbas C, Ulusoy H, Yulug E, et al. One-lung ventilation: for how long? Journal of Thoracic and Cardiovascular Surgery 2007; 134: 40510.
  • 9
    De Conno E, Steurer MP, Wittlinger M, et al. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology 2009; 110: 131626.
  • 10
    Theroux MC, Olivant A, Lim D, et al. Low dose methylprednisolone prophylaxis to reduce inflammation during one-lung ventilation. Pediatric Anesthesia 2008; 18: 85764.
  • 11
    Leflein JG, Gawchik SM, Galant SP, et al. Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma. Allergy and Asthma Proceedings 2001; 22: 35966.
  • 12
    Baker JW, Kemp J, Uryniak T, Silkoff PE. Asthma control in pediatric patients treated with once-daily or twice-daily nebulized budesonide inhalation suspension (Pulmicort Respules). Allergy and Asthma Proceedings 2008; 29: 2805.
  • 13
    Cook RO, Pannu RK, Kellaway IW. Novel sustained release microspheres for pulmonary drug delivery. Journal of Controlled Release 2005; 104: 7990.
  • 14
    Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Annals of Thoracic Surgery 2000; 69: 37680.
  • 15
    Carden DL, Granger DN. Pathophysiology of ischemia reperfusion injury. Journal of Pathology 2000; 190: 25566.
  • 16
    Whitehead TC, Zhang H, Mullen B, Slutsky AS. Effect of mechanical ventilation on cytokine response to intratracheal lipopolysaccharide. Anesthesiology 2004; 101: 528.
  • 17
    Dreyfuss D, Rouby JJ. Mechanical ventilation-induced lung release of cytokines: a key for the future or pandora's box? Anesthesiology 2004; 101: 13.
  • 18
    Fernández-Pérez ER, Keegan MT, Brown DR, Hubmayr RD, Gajic O. Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy. Anesthesiology 2006; 105: 148.
  • 19
    Ohta N, Shimaoka M, Imanaka H, et al. Glucocorticoid suppresses neutrophil activation in ventilator-induced lung injury. Critical Care Medicine 2001; 29: 10126.
  • 20
    Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. American Journal of Respiratory and Critical Care Medicine 2001; 163: 7116.
  • 21
    Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. Journal of American Society Nephrology 2009; 20: 241225.
  • 22
    Sun J, Yang D, Li S, Xu Z, Wang X, Bai C. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats. European Respiratory Journal 2009; 33: 398404.
  • 23
    Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. American Journal of Respiratory and Critical Care Medicine 2002; 165: 698703.
  • 24
    Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. New England Journal of Medicine 1997; 337: 140511.
  • 25
    Wang J, Zhang L, Walther SM. Inhaled budesonide in experimental chlorine gas lung injury: influence of time interval between injury and treatment. Intensive Care Medicine 2002; 28: 3527.
  • 26
    Tönz M, Bachmann D, Mettler D, Kaiser G. Pulmonary function after one-lung ventilation in newborns: the basis for neonatal thoracoscopy. Annals of Thoracic Surgery 1998; 66: 5426.
  • 27
    O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomised trial. American Journal of Respiratory and Critical Care Medicine 2001; 164: 13927.
  • 28
    Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 21924.
  • 29
    Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. American Journal of Respiratory and Critical Care Medicine 1996; 153: 14818.
  • 30
    Laviolette M, Malmstrom K, Lu S, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. American Journal of Respiratory and Critical Care Medicine 1999; 160: 18628.
  • 31
    Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. American Journal of Respiratory and Critical Care Medicine 2002; 165: 98391.
  • 32
    You Z, Feng D, Xu H, et al. Nuclear factor kappa-B mediates one-lung ventilation-induced acute lung injury in rabbits. Journal of Investigative Surgery 2012; 25: 7885.
  • 33
    Madjdpour C, Jewell UR, Kneller S, et al. Decreased alveolar oxygen induces lung inflammation. American Journal of Physiology Lung Cellular Molecular Physiology 2003; 284: L3607.
  • 34
    Vozzelli MA, Mason SN, Whorton MH, Auten RL Jr. Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxiaexposed newborn rat lung. American Journal of Physiology Lung Cellular Molecular Physiology 2004; 286: L48893.
  • 35
    Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer RC. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respiratory Research 2005; 6: 61.
  • 36
    Schilling T, Kozian A, Kretzschmar M, et al. Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. British Journal of Anaesthesia 2007; 99: 36875.
  • 37
    Schilling T, Kozian A, Senturk M, et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology 2011; 115: 6574.
  • 38
    Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. The Journal of Biological Chemistry 2001; 276: 2960310.
  • 39
    Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase-1 and phosphatase-mediated inhibition of MAPK. Molecular and Cellular Biology 2002; 22: 780211.
  • 40
    McKay DM, Brattsand R, Wieslander E, Fung M, Croitoru K, Perdue MH. Budesonide inhibits T cell-initiated epithelial pathophysiology in an in vitro model of inflammation. Journal of Pharmacology and Experimental Therapeutics 1996; 277: 40310.
  • 41
    Wilson SJ, Wallin A, Della-Cioppa G, Sandström T, Holgate ST. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. American Journal of Respiratory and Critical Care Medicine 2001; 164: 104752.
  • 42
    Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts. European Respiratory Journal 2000; 15: 6874.
  • 43
    Kerr KM, Auger WR, Marsh JJ, et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 2012; 141: 2735.
  • 44
    Celik JB, Gormus N, Okesli S, Gormus ZI, Solak H. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-α, IL-6, IL-8, IL-10. Perfusion 2004; 19: 18591.
  • 45
    John M, Lim S, Seybold J, et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. American Journal of Respiratory and Critical Care Medicine 1998; 157: 25662.
  • 46
    Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 17: 116272.